Excellent summary. Hope SEC investigates this scrooge of market manipulation. On flip side, blame is on weak retails if they sell while wise longs have added on the dip.
What's most damning re Scorpion's true beliefs and motivations in their $ABVX short report can be seen in this tweet. Scorpion stated in their initial report (in a small font legal disclaimer) that "upon the publication of this report we intend to begin covering a substantial part of our short position".
Yet, in this tweet they also claim they "we don’t think the $ABVX drug will ever make it that far". "That far" meaning the anticipated upcoming FDA approval.
$ABVX closed down -9.24% end of day Friday, and is back up +4.46% in after hours trading. It is still worth about ~$7Bn and is a one drug company.
If you really believed $ABVX is not going to make it through FDA approval, and of course would therefore be a true zero, and if you really stood by the merits of your short report in which you claimed this was a "biotech fraud for the ages", why on earth would you substantially close your position when $ABVX is still trading at $7Bn?! It is not even below where it was when it released its exceptional Phase III induction data!!!
This contradiction, more than anything else, reveals what this report was actually about. A predatory scam to score an easy, low-risk, low IQ, get in and get out win, preying on an easily predictable short-term (largely retail) reaction, amplified by the current dynamics within the biotech market (outlined previously) and across the broader market.
What's further interesting is Scorpion's track record page only lists their short performance through 2024....and over the 2022-2024 timeframe, two of the three shorts they took over that multi-year timeframe look like they may have been either neutral or a big money loser for them, depending on when they closed their position. Hardly market beating performance...
scorpioncapital.com/track-re…
It begs the question whether in a market where there have been plenty of opportunities to find and participate in quality shorts and a whole lot of returns to find elsewhere, these guys simply do not have the capability to find any more good short ideas, no longer even think of themselves as sharp enough to make an authentic high-conviction short, are panicking under LP pressure regarding a lack of performance, and therefore have chosen to resort to scammy and intellectually bereft tactics to try and make an easy, low-risk buck and hold on to their management fees.
Scorpion probably is substantially or entirely out as they said they would be. However, imagine if the bizarre follow-up attacks on ADAR1 and Adam reflected a world in which $ABVX hadn't dropped enough to save them their performance, and they hung on to the position out of desperation for more of a drop....boy, would it be just desserts for these guys to get squeezed.
2
873
$ABVX The clearest rebuttal is ABTECT-2. The report implies obefazimod’s Phase 3 efficacy depended on questionable Chinese sites. ABTECT-2 enrolled 636 patients across 27 countries, with no listed sites in China, and the 50 mg dose beat placebo on week-eight clinical remission by 13.4 percentage points (p = 0.0001).
Bios_n_Techs retweeted
we have never seen a company even 30% of the size of $NVDA DO 100% growth
and its trading at 9X forward earnings
wild
and they just guided 2027 to 75% growth
Bios_n_Techs retweeted
NEW: Measles had become so rare in the U.S. that doctors had never seen a case. Now they’re treating adults w severe pneumonia, pregnant women + babies infected before or shortly after birth.
What docs are seeing as measles spreads again. My story 1/3
washingtonpost.com/health/20…
You know whose fault this is…
EXCLUSIVE: The U.S. has lost its measles elimination status.
with @JenCalfas - free link: wsj.com/health/u-s-loses-mea…
1,077
Bios_n_Techs retweeted
$VIR presentation further reinforced view that data
for tobevibart + elebsirian support a meaningful ($1B+) opportunity in HDV
ahead of ECLIPSE-2/3 data in 1Q27 and FDA filing in mid-2027. Of note, Vir
estimates ~61K active viremic patients in the US and only ~3-4K patients would
be needed to reach ~$1B in sales. ECLIPSE-1 demonstrates fast, deepening responses, consistent across cirrhosis
status. Recall virologic response exceeded 90% by week 4, and TND rose from 24%
at week 12 to 79% at week 48 with no sign of a plateau $GILD $SNY
$VIR MS ⬆️PT $28 multiple data updates at AASLD including Ph3 data,
Vir hosted a webcast, highlighting treatment with elebsiran+
tobevibart results in rapid and robust activity that notable
deepens over time. data increase conviction in the HDV
opportunity increase our PT to $28.
Bios_n_Techs retweeted
SEC Filing: FMR LLC increased its position in $AVR (7.33M -> 8.48M shares) | Ownership 8.7%
Bios_n_Techs retweeted
You let a demented old man run wild. He imposed tariffs, insulted allies, threatened Greenland, started a war with Iran, blew up boats at will, terrorized US cities, gutted healthcare, and pursued endless vanity projects while you clapped like seals. Now you’re all unemployed spineless cowards.
Bios_n_Techs retweeted
I hate to say this as a former Republican, but the path to the presidency deserves to be closed for now and for a good long time.
This country has never experienced such a degree of corruption, criminality, cruelty, incompetence, misguidedness and confusion, and bad faith coming from the executive branch of government. It's as though our government was commandeered by a hostile foreign power as a fifth column attack and maybe it was. It's almost as though the institutional damage is intentional, a sabotage of the gift that is our inheritance.
This was all out in the open, obvious, clear as day and the GOP didn't do a damn thing to place country first and defend her. Inexcusable! Maybe even criminal!
The Republican Party should maybe not even be allowed to continue to exist after its war against America. Conservative? This isn't Conservatism. Since when is arson and vandalism Conservative? Everything this party has done during the era of Trump is permanently destructive to the United States of America and has cheapened all that had made God's greatest creation beautiful.
Please give us the strength to unite once again and rebuild that which has been lost and destroyed by the very worst of humanity that currently occupies our executive branch of government.
At least finally America is beginning to wake up and get it.
Bios_n_Techs retweeted
BREAKING: Donald Trump and his top White House aides are reportedly preparing to directly blame Defense Secretary Pete Hegseth for the Republican midterm defeat, along with military commanders who pushed for war with Iran, per CNN and CBS News.
“Trump, always one to crowdsource an opinion, has asked allies about their thoughts on Hegseth’s performance of late,” sources told CNN.
CBS News also reports that Trump believes the election results would have been entirely different without the Iran war. Joint Chiefs Chairman Gen. Dan Caine and CENTCOM commander Gen. Brad Cooper are also reportedly facing scrutiny as Trump looks for someone to blame for the Republican midterm defeat.
Bios_n_Techs retweeted
Future generations are gonna look at this piece of shit and ask if we were all high.
What a massive win for the Democratic Party!
Agree or not, the last two years of policies, including tariffs and the ongoing wars, have backfired politically.
Ordinary Americans care about their cost of living, grocery bills, housing, healthcare and rising prices. They feel the impact in their daily lives.
When people struggle to afford everyday expenses, political rhetoric only goes so far.
Good night.
$MSFT tip of an iceberg likely as whatever AI adoption reason co is quoting, applying meanwhile for H1B visas to get low wage workers to replace US citizens with is non-stop.
BREAKING: Microsoft, $MSFT, is offering buyouts to 60,000 workers as part of the company’s efforts to cut costs amid AI adoption, per Bloomberg.
Personnel on select teams in the US, Canada, India, and the UK at a vice president level and below will be eligible.
This reflects ~27% of Microsoft's total workforce.
876
Bios_n_Techs retweeted
NEARLY 1 OUT OF 3 (60,000 EMPLOYEES) AT MICROSOFT BEING OFFERED VOLUNTARY TERMINATION
Emails should be going out any minute to those receiving the offer.
Absolutely insane.
$MSFT offers 60,000 employees a voluntary exit.
60K Y’all!!
First time this has ever been offered at Microsoft and it will affect employees in India, The United States, Canada, and the UK at level 70 or below…
Employees find out in a few hours if they are being targeted for this.
This just makes me think that H127 layoffs sound intense. Is this a pre-layoff round?
Also makes me wonder if they changed some scheduled layoffs due to be called out by @VP. Peace offering? 🤔 Timing is just interesting.
More to come.
Bios_n_Techs retweeted
A rabbi's response to our President calling Jews "lacking knowledge and disloyal" if they vote Democratic:
Rabbi Danny Maseng writes:
As a Jew
Since you called me out as a Jew, Mr. President, since you thought to call me disloyal or lacking knowledge by not voting for you, I’d like to respond to you personally, even though I have no illusions you will read this.
As a Jew, Mr. President, I am commanded to love the stranger who dwells among us no less than thirty-six times in the Bible you claim to treasure. I am commanded to have one law for the stranger and the citizen. No exceptions.
As a Jew, Mr. President, I am commanded to pay my employees on time, including undocumented workers at casinos, construction sites, or golf courses.
As a Jew, I am commanded to repay bank loans and investors.
As a Jew, I am commanded to never bear false witness.
As a Jew, Mr. President, I am commanded to guard my tongue and speak no evil.
As a Jew, Mr. President, I am commanded to never embarrass my fellow human being in public, lest I be accused of spilling their blood – including Ted Cruz or the late Senator and war hero, John McCain.
As a Jew, Mr. President, I take great offense in my president attacking Denmark, a country that gallantly saved its Jews from the Nazis, while most of Europe fell asleep.
As a Jew, Mr. President, I take umbrage in my Grandfather, the sainted Dr. Rabbi Harry S. Davidowitz, who inhaled poison gas in the trenches of WWI as a US Army chaplain, being called disloyal because he voted Democrat.
As a Jew, born and raised in Israel, I take offense at you calling me disloyal to America AND to Israel because I oppose your inept, ghoulish, uncouth, deceitful, inhumane farce of leadership. How many tours of duty have you performed for Israel during wartime? Or, for that sake, the USA?
As a Jew, Mr. President, I reserve the right to oppose Ilhan Omar and Rashida Tlaib (neither of whom called upon the help of a former KGB operative to help them in their election to office), while simultaneously condemning your divisive, racist rants and policies.
As a Jew who has proud Republican family members who I love and cherish, I am ashamed of what you have done to the Republican party; to conservative ideals – even if I do not share all of those ideals.
As a Jew whose Christian uncle fought heroically at the Battle of the Bulge for our country and for the salvation of Europe – I am ashamed by the mockery you visit upon his sacrifice.
As the son of a Christian pilot, later converted to Judaism, who led American pilots to glorious victory over Nazi Germany, I am outraged by your embrace of neo-Nazi’s and racists in America (that same pilot, who became a squadron commander in the Israeli Air Force, and fought for Israel’s independence).
As a Jew, I am disgraced by your fawning adoration of the worst dictators of our century – you violate Christian and Jewish values by doing so.
As a Jew; as a well-informed Jew who loves and cares deeply for Israel and for America, I condemn you and call you out for the divisive fool, the ogre, the ghoul that you are.
May my soul not enter your council, let me not join your assembly.
Great news for U.S.-based biotech companies competing in the obesity market
Bullish for $VKTX and potentially a headwind for China-based obesity drug developers.
A competitive advantage for domestic players could reshape the landscape.
Pharma is bracing for tougher Treasury scrutiny of China deals, with draft outbound investment rules expected Thursday.
endpoints.news/treasury-expe…





























